Schedule 13D ownership disclosure

Akebia Therapeutics Inc

Security class unavailable · CUSIP: 00972D105

Event date: 2018-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-212523
Form type
SC 13D/A
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Jul 03, 2018
Reporting period
Jun 28, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub